Newsroom
Newsroom
Industry News
Antheia Inc., Menlo Park, $73 million: Viking Global Investors led the Series B funding of this company that's making plant-based medicines using synthetic biology. Sherpalo...
Industry News
Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and...
Industry News
The idea: A California company producing active pharmaceutical ingredients with engineered yeast raised $73 million to bring its first product to market......
Industry News
Any doubts about synthetic biology’s attractiveness to investors were likely shattered during the first quarter, when investors pumped $4.6 billion into such companies—more than four...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced today that it has raised $73M in Series B financing. The oversubscribed round was led...
Industry News
Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and...